home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops
Search  -  prev / next
 
 

Regulatory Compliance Basics for Medical Device, Pharmaceutical, Biologic, and Combination Product

 
  January 28, 2019  
     
 
CfPA-The Center for Professional Advancement, Amsterdam, The Netherlands
3-4 July 2019


Who Should Attend?
Professionals in the Pharmaceutical, Biologic, Medical Device and Combination Products industries who will benefit most by attending this course include:
  • Senior management, RA, RC, QA, QC
  • Quality, Manufacturing, and Design engineers
  • Sales and Marketing, Maintenance, and Operational personnel, and Healthcare professionals
  • Anyone else who manages, assesses, or performs any related quality work
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   George Calafactor, Former FDA Investigator, Regulatory Compliance Consultant

George Calafactor is a 33-year food, cosmetic, drug, biologic, clinical, and medical device non-technical quality assurance and regulatory compliance veteran with over 21 years of FDA/ governmental experience as an analyst and level II certified international medical device investigator and over 10 years of industrial experience as a biologic, pharmaceutical, and medical device industry quality assurance consultant, regulatory compliance specialist, and ASQ certified quality biomedical auditor. 

Mr. Calafactor’s educational background includes 2 BS degrees in Chemistry and Metallurgical Engineering from the University of Notre Dame, an MBA in International Business from Indiana University, and a MS in Regulatory Affairs for Drugs, Biologics, and Medical Devices with a concentration in Regulatory Compliance from Northeastern University.

Mr. Calafactor not only has inspected, investigated, and audited all types of US and foreign food, cosmetic, drug, biologic, medical device, and clinical facilities, but has also performed various pharmaceutical and medical device quality assurance and regulatory compliance operations, such as monitoring and maintaining product and quality system failure investigations, non-conformances, complaints/ MDRs, and CAPAs, reconciling and analyzing numerous quality system data, writing and revising numerous top and mid-level written procedures, training various governmental and industry personnel in the areas of medical device quality, quality system, design control, and documentation and change control, and informing management and staff of current FDA and EU enforcement policies.

 


 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.